The Siesta Group

Vienna, Austria· Est. 2002

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

The Siesta Group is a Vienna-based, neuroscience-focused service provider that empowers CNS drug development through advanced analysis of EEG, sleep, and activity data. Leveraging over 20 years of experience, proprietary AI-powered analysis tools, and a strong scientific network, the company helps sponsors identify biomarkers and endpoints for conditions ranging from sleep disorders to neurodegenerative diseases. It operates as a trusted partner to over 30 leading sponsors and CROs, offering a full suite of clinical trial services from feasibility to data visualization, all while maintaining rigorous compliance standards.

Sleep DisordersSleep ApneaNeurodegenerative DiseasesMood DisordersSchizophreniaAutismAnxiety Disorders

Technology Platform

Proprietary AI-powered analysis platform for EEG, polysomnography (PSG), and actigraphy data. Includes next-generation sleep staging, disease-specific biomarker identification, advanced data visualization (EEG topography, 3D source localization), and open-source tools (pyedfio EDF library). Also hosts the open-access Hypoxic Burden Platform for sleep apnea research.

Opportunities

The growing demand for objective digital biomarkers in CNS clinical trials, driven by high failure rates and regulatory push, presents a major growth opportunity.

Expansion into analysis of data from wearable devices and support for decentralized trials could further broaden its market.

The company's proprietary tools and scientific leadership position it to set new industry standards and capture value as a preferred specialist partner.

Risk Factors

Business is dependent on pharmaceutical R&D spending, particularly in the volatile CNS sector.

Technological obsolescence and competition from new analytical platforms or larger CROs building internal capabilities are constant threats.

Operational risks include maintaining flawless data security, regulatory compliance, and quality across global trials, where any failure could severely damage reputation.

Competitive Landscape

The Siesta Group competes with other specialized central reading labs and EEG/PSG service providers, as well as the internal capabilities of large, full-service CROs. Its differentiation lies in its deep scientific focus on CNS, proprietary AI and visualization software, and two decades of niche experience. It may face competition from pure-play digital biomarker and AI analytics startups entering the clinical trial space.